v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net income $ 14,346 $ 11,620
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:    
Depreciation and amortization expense 5,696 2,933
Provision for doubtful accounts 104 88
Deferred income tax benefit (1,179) (163)
Share-based compensation expense 3,574 2,810
Gain on disposal of fixed assets (5) 0
Amortization of discount on accounts receivable (34) (23)
Amortization of right-of-use assets 448 307
Change in fair value of contingent earn-out consideration 1,374 1,152
Changes in operating assets and liabilities:    
Accounts receivable 124,269 (24,145)
Inventory (579) (690)
Prepaid expenses and other current assets (3,118) 435
Accounts payable and accrued expenses (116,139) 25,407
Lease liability, net (502) (361)
Other assets and liabilities 240 (1,608)
Net cash and cash equivalents provided by operating activities 28,495 17,762
Cash flows from investing activities    
Purchase of equipment and leasehold improvements and capitalization of internal-use software (1,672) (3,592)
Payment for acquisition 0 (20,672)
Net cash and cash equivalents used in investing activities (1,672) (24,264)
Cash flows from financing activities    
Purchase of treasury stock (1,730) (1,030)
Repayments of borrowings under credit facilities 0 (4,252)
Repayments of borrowings under term loan (418) (403)
Dividends paid (2,305) (2,275)
Contingent consideration paid (3,559) (152)
Net cash and cash equivalents used in financing activities (8,012) (8,112)
Effect of foreign exchange rate on cash and cash equivalents 1,253 458
Net increase in cash and cash equivalents 20,064 (14,156)
Cash and cash equivalents at beginning of period 29,778 36,295
Cash and cash equivalents at end of period 49,842 22,139
Supplementary disclosure of cash flow information:    
Income taxes paid 6,889 2,867
Interest paid $ 114 $ 177

Source